SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SILVER is a crypto project that links traditional silver with digital assets. Each unit of SILVER is backed by an equal amount of $SILVER tokens, ensuring stable value and easy trading in a secure blockchain environment. With SILVER, users can convert real silver into digital assets and trade globally with low fees. Each $SILVER token is backed by actual silver, offering stability and reliability for investors to grow their wealth. SILVER is a crypto project that links traditional silver with digital assets. Each unit of SILVER is backed by an equal amount of $SILVER tokens, ensuring stable value and easy trading in a secure blockchain environment. With SILVER, users can convert real silver into digital assets and trade globally with low fees. Each $SILVER token is backed by actual silver, offering stability and reliability for investors to grow their wealth.

SILVER

Silver is experiencing significant upward momentum, with community discussions intensifying around a potential "silver squeeze" and historical allegations of bank manipulation. The market is actively debating whether this "parabolic action" represents a fundamental breakout or a speculative "momentum bubble."

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as its community champions it as the ultimate tokenization of the Satoshi Nakamoto name and cultural legacy, effectively the "Bitcoin of memes." Enthusiasts believe it embodies the core identity of the crypto industry, hailing it as a timeless, deeply meaningful asset with unparalleled long-term growth potential.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp ($OMER) is trending following the FDA approval of YARTEMLEA, its first-and-only therapy for transplant-associated thrombotic microangiopathy (TA-TMA), with a U.S. launch slated for early January. Investors are highly optimistic about the drug's market monopoly and pricing power, alongside the company's bolstered financial position from a major partnership. Community discussions are vibrant, with many anticipating further positive updates like potential European collaborations during the upcoming conference call, while others remain cautious of short-term volatility.

Powell Industries, Inc. engages in the development, design, manufacturing, and provision of services for custom-engineered products and systems. Its products include integrated power control room substation, electrical houses, traditional and arc-resistant distribution switch gear and control gear, medium-voltage circuit breakers, monitoring and control communications systems, motor control centers, and bus duct systems. The company was founded by William E. Powell in 1947 and is headquartered in Houston, TX.

Powell Industries, Inc.

Powell Industries is currently trending following strong recent earnings that highlight expanding gross margins and significant growth in its electric utility and data center segments. The community is actively discussing its strategic diversification into critical energy infrastructure and LNG, alongside a robust balance sheet and substantial backlog. Many view POWL as an undervalued opportunity amid increasing demand for energy infrastructure and AI buildout, also fueling speculation around a potential short squeeze.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending due to its ongoing achievements in regulatory compliance, notably ISO 20022, positioning it as a crucial player in the future of real-time payroll and payment infrastructure. The community remains highly bullish, actively discussing upcoming Super App features and strategic partnerships, with many viewing current price levels as an accumulation opportunity for a long-term hold.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is experiencing a surge in bullish sentiment, with the community actively anticipating a significant price breakout driven by strong technical signals and its enduring "digital silver" identity. Many believe a substantial run, potentially linked to an upcoming halving cycle, is imminent after prolonged consolidation, positioning LTC for notable upward momentum.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is a trending topic, fueled by recent technological advancements like quantum-safe state proofs and Liquid Auth, alongside significant ecosystem activity including the Folks Finance token airdrop. The community is sharply divided between steadfast long-term accumulators banking on its core technical strengths and future institutional adoption, and vocal critics expressing frustration over perceived management issues, tokenomics concerns, and prolonged market underperformance. This polarization highlights ongoing debate regarding the project's ability to translate its technological edge into broader market success amidst fluctuating altcoin sentiment.

AGNC Investment Corp. engages in the operation of a real estate investment trust. The firm invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It also invests in other types of mortgage and mortgage-related securities, such as credit risk transfer securities and non-Agency residential and commercial mortgage-backed securities, where repayment of principal and interest is not guaranteed by the United States government-sponsored enterprise or by the United States Government agency, and other assets related to the housing, mortgage, or real estate markets. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

AGNC Investment Corp

AGNC Investment Corp. is trending amid recent Q1 performance updates and analyst rating shifts, drawing significant community attention. Many investors are keenly focused on its attractive monthly dividend, actively accumulating shares and debating its sustainability while anticipating how evolving interest rate expectations will influence future price action. Despite some valuation concerns, the mREIT remains a key discussion point for its income potential in the current market environment.

Gold.com, Inc. engages in the trading of gold, silver, platinum, and palladium bullion numismatic coins, and related products. It operates through the following segments: Wholesale Trading and Ancillary Services, Direct-to-Consumer, and Secured Lending. The Wholesale Trading and Ancillary Services segment is involved in the distribution and purchasing of metal products from sovereign and private mints. The Direct-to-Consumer segment provides access to a multitude of products through its wholly owned subsidiaries. The Secured Lending segment includes coin and precious metal dealers, investors, and collectors. The company was founded by Steven C. Markoff on April 9, 1965 and is headquartered in El Segundo, CA.

Gold.com Inc.

Gold, the commodity, is experiencing significant attention after recently hitting new all-time highs, sparking community debate on whether this represents a sustainable "global repricing" driven by macroeconomic shifts. Traders are actively discussing buying opportunities on dips and the broader implications for gold miners, amid a wider rally in precious metals that some connect to de-dollarization trends and inflation concerns.

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

BeOne Medicines Ltd - ADR

BeiGene Ltd - ADR

BeiGene (ONC) is trending amid a continuous stream of positive drug development news, including recent FDA Fast Track and Priority Review designations, along with multiple approvals for its key oncology therapies, Brukinsa and Tevimbra. The community is actively discussing its robust pipeline, significant market share gains against competitors, and strong financial performance, which has led to widespread analyst upgrades and M&A speculation. This momentum is reinforced by the company's strategic rebrand to 'BeOne Medicines' as it solidifies its global oncology footprint.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

John malar

$SPRY  $MIRM 

NEFFY had a massive showing at the Piper Sandler conference. Adoption is taking off with over 20,000 prescribers and the count doubling in the last three months. Doctors trying it keep using it, and real-world data now shows it works the same as injectable epinephrine, which removes the last hesitation.

Awareness has jumped from under 20 percent to over 50 percent thanks to TV and digital campaigns. The GET NEFFY program is a major catalyst with zero copay, zero virtual visit cost, fast online approval, and doctors using it to bypass prior authorizations. This removes almost all friction for switching.

Coverage is improving fast. Optum and Express Scripts are on board, Blue Cross plans are coming in gradually, and eight Medicaid states already list NEFFY as preferred. As coverage expands, adoption expands.

Real-world performance is strong: Japan Phase 3 showed 100 percent response, and the U.S. experience program (680+ patients) showed the classic 90 percent one-dose response seen with injections. NEFFY is now fully validated clinically and practically.

NEFFY is also growing the market. About 80 percent of prescriptions are switchers, but 20 percent are new patients who either never filled an autoinjector or never had epinephrine at all. This taps into the huge underserved group of people who should be carrying epinephrine but aren’t.

Needle-free delivery also opens doors for airlines, schools, restaurants, and first responders who avoided autoinjectors due to liability. This institutional channel could be a major tailwind.

International pricing is excellent. Europe and Canada come in at more than twice EpiPen pricing, Japan’s net price is higher than the U.S., and more regions are expected to approve in 2026. Germany, which has no payer barriers, is seeing strong market share growth — a preview of U.S. adoption as friction continues to fall.

Competition isn’t viewed as a threat. The market is massively underpenetrated, and new entrants would likely grow the category rather than hurt NEFFY.

On top of that, CSU is emerging as a second major opportunity. NEFFY showed rapid itch reduction in five minutes, Phase 2b is underway with a lower dose, and Phase 3 is expected to start at the end of 2025. This could become a blockbuster second indication.

Bottom line: NEFFY is scaling fast, expanding the market, winning with patients and doctors, gaining payer support, growing internationally, opening institutional demand, and adding a second major pipeline indication. Everything is lined up for a strong 2025 and 2026.